Active 0 6 0 6 O
malignancy 7 17 7 17 B-cancer
, 17 18 17 18 O
metastatic 19 29 19 29 B-cancer
disease 30 37 30 37 I-cancer
, 37 38 37 38 O
or 39 41 39 41 O
anyone 42 48 42 48 O
undergoing 49 59 49 59 B-treatment
treatment 60 69 60 69 I-treatment
for 70 73 70 73 O
malignancy 74 84 74 84 O

American 0 8 85 93 O
Cancer 9 15 94 100 O
Society 16 23 101 108 O
( 24 25 109 110 O
ACS 25 28 110 113 O
) 28 29 113 114 O
guidelines 30 40 115 125 O
recommend 41 50 126 135 O
having 51 57 136 142 O
a 58 59 143 144 O
discussion 60 70 145 155 O
about 71 76 156 161 O
screening 77 86 162 171 O
in 87 89 172 174 O
men 90 93 175 178 O
who 94 97 179 182 O
have 98 102 183 187 O
an 103 105 188 190 O
expected 106 114 191 199 O
mortality 115 124 200 209 O
of 125 127 210 212 O
greater 128 135 213 220 O
than 136 140 221 225 O
10 141 143 226 228 B-lower_bound
years 144 149 229 234 I-lower_bound
; 149 150 234 235 O
data 151 155 236 240 O
on 156 158 241 243 O
comorbidities 159 172 244 257 O
and 173 176 258 261 O
10 177 179 262 264 O
- 179 180 264 265 O
year 180 184 265 269 O
mortalities 185 196 270 281 O
will 197 201 282 286 O
be 202 204 287 289 O
collected 205 214 290 299 O
on 215 217 300 302 O
every 218 223 303 308 O
participant 224 235 309 320 O
using 236 241 321 326 O
the 242 245 327 330 O
University 246 256 331 341 O
of 257 259 342 344 O
California 260 270 345 355 O
at 271 273 356 358 O
San 274 277 359 362 O
Francisco 278 287 363 372 O
( 288 289 373 374 O
UCSF 289 293 374 378 O
) 293 294 378 379 O
mortality 295 304 380 389 O
index 305 310 390 395 O

Known 0 5 396 401 O
personal 6 14 402 410 O
history 15 22 411 418 O
of 23 25 419 421 O
prostate 26 34 422 430 B-cancer
cancer 35 41 431 437 I-cancer

Men 0 3 438 441 B-gender
over 4 8 442 446 O
the 9 12 447 450 O
age 13 16 451 454 B-age
of 17 19 455 457 O
18 20 22 458 460 B-lower_bound
will 23 27 461 465 O
be 28 30 466 468 O
asked 31 36 469 474 O
to 37 39 475 477 O
participate 40 51 478 489 O
in 52 54 490 492 O
the 55 58 493 496 O
educational 59 70 497 508 O
component 71 80 509 518 O
of 81 83 519 521 O
the 84 87 522 525 O
program 88 95 526 533 O

men 0 3 534 537 B-gender
over 4 8 538 542 O
age 9 12 543 546 B-age
40 13 15 547 549 B-lower_bound

men 0 3 550 553 B-gender
over 4 8 554 558 O
the 9 12 559 562 O
age 13 16 563 566 B-age
of 17 19 567 569 O
18 20 22 570 572 B-lower_bound

men 0 3 573 576 B-gender
over 4 8 577 581 O
the 9 12 582 585 O
age 13 16 586 589 B-age
of 17 19 590 592 O
40 20 22 593 595 B-lower_bound
will 23 27 596 600 O
be 28 30 601 603 O
offered 31 38 604 611 O
the 39 42 612 615 O
screening 43 52 616 625 O
component 53 62 626 635 O
after 63 68 636 641 O
the 69 72 642 645 O
educational 73 84 646 657 O
portion 85 92 658 665 O
of 93 95 666 668 O
the 96 99 669 672 O
event 100 105 673 678 O

participants 0 12 679 691 O
over 13 17 692 696 O
age 18 21 697 700 B-age
of 22 24 701 703 O
40 25 27 704 706 B-lower_bound
will 28 32 707 711 O
have 33 37 712 716 O
the 38 41 717 720 O
opportunity 42 53 721 732 O
to 54 56 733 735 O
make 57 61 736 740 O
an 62 64 741 743 O
informed 65 73 744 752 O
decision 74 82 753 761 O
in 83 85 762 764 O
regards 86 93 765 772 O
to 94 96 773 775 O
prostate 97 105 776 784 B-cancer
cancer 106 112 785 791 I-cancer
screening 113 122 792 801 O
based 123 128 802 807 O
on 129 131 808 810 O
this 132 136 811 815 O
information 137 148 816 827 O
and 149 152 828 831 O
the 153 156 832 835 O
educational 157 168 836 847 O
material 169 177 848 856 O

